Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine as an Adjunct Therapy in Rheumatoid Arthritis
NCT07497282Phase 2Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Mar 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of venlafaxine in rheumatoid arthritis (RA), sponsored by Ain Shams University. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
venlafaxine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07497282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07497282.